Fabio Bertozzi
D3 PharmaChemistry
Phone
+39 010 2896 235
Research center
CCT@Morego
About
All Publications
2021
Di Fruscia P., Carbone A., Bottegoni G., Berti F., Giacomina F., Ponzano S., Pagliuca C., Fiasella A., Pizzirani D., Ortega J.-A., Nuzzi A., Tarozzo G., Mengatto L., Giampà R., Penna I., Russo D., Romeo E., Summa M., Bertorelli R., Armirotti A., Bertozzi S.M., Reggiani A., Bandiera T., Bertozzi F.
Discovery and SAR evolution of pyrazole azabicyclo[3.2.1]octane sulfonamides as a novel class of non-covalent N-Acylethanolamine-hydrolysing Acid Amidase (NAAA) inhibitors for oral administration
Journal Medicinal Chemistry
Article
Journal
2021
Sgroi S., Romeo E., Di Fruscia P., Porceddu P-F., Russo D., Realini N., Albanesi E., Bandiera T., Bertozzi F., Reggiani A.
Inhibition of N-Acylethanolamine-hydrolysing Acid Amidase reduces T-cell infiltration in a mouse model of multiple sclerosis
Pharmacological Research, vol. 172, pp. 105816
Article
Journal
2021
Capurro V., Tomati V., Sondo E., Renda M., Borrelli A., Pastorino C., Guidone D., Venturini A., Giraudo A., Bertozzi S.M., Bertozzi F., Bandiera T., Zara F., Galietta L.J.V., Pedemonte N.
Partial rescue of F508del-CFTR stability and trafficking defects by double corrector treatment
International Journal of Molecular Science, vol. 22, (no. 10), pp. 5262
Article
Journal
2021
Rapposelli S., Gaudio E., Bertozzi F., Gul S.
Protein-Protein Interactions: drug discovery for the future
Frontiers in Chemistry, vol. 9, pp. 811190
Editorial
Journal
2020
Pedemonte N., Bertozzi F., Caci E., Sorana F., Fruscia P.D., Tomati V., Ferrera L., Rodriguez-Gimeno A., Berti F., Pesce E., Sondo E., Gianotti A., Scudieri P., Bandiera T., Galietta L.J.V.
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
Science advances, vol. 6, (no. 8)